Part 1: Case Background and Pre-Procedural Planning

An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features in 11 videos on Wondr Medical. Alan Yeung generally speaks on MitraClip, Mitral, Live Cases, Bifurcation, and Intravascular Ultrasound (IVUS).

Works at Clinica Mediterranea, Naples, Italy. Features in 10 videos on Wondr Medical. Carlo Briguori generally speaks on MitraClip, Mitral, Live Cases, Bifurcation, and Intravascular Ultrasound (IVUS).

Works at Infermi Hospital, Rivoli and San Luigi Gonzaga Hospital, Orbassano, Italy. Features in 10 videos on Wondr Medical. Ferdinando Varbella generally speaks on MitraClip, Mitral, Live Cases, Bifurcation, and Intravascular Ultrasound (IVUS).

Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.

Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

Dr Sunao Nakamura is one of the most experienced interventional cardiologist Japan. He had performed more than 25,000 cases of PCI and 10,000 cases of chronic total occlusion (CTO) which is a biggest numbers in the world. He has a very unique background as a researcher; studying about cellular electro-physiology for 6 years and clinical sciences for 4 years in his younger days. After that he suddenly changed his main field of cardiology; Interventional cardiology with respect of Prof. Shigeru Saito ; who was active in the leadership position in Asia region, Dr. Nakamura worked disseminate PCI in Asia from his age early 30s and experienced living a half of the year in foreign countries. As a result of through these actives over the years, he has built good relations with many doctors who share the same goals all over the world. His motto is that patients around the world should be saved not only we think about the patients who come here to our hospital by sharing each other’s skills and knowledge. He is also fully engaged in the leading edge of clinical activities and researches, and at his New Tokyo Hospital, many clinical and basic studies are conducted every year, and about 30 papers are published annually. Especially in close relation with Professor Antonio Colombo, Italy, our young doctors who received his guidance are active not only as a physician but also as a medical scientist in New Tokyo Hospital. His dream is to make the world's leading heart center capable of medical research from basic to clinical.